| H0001 |
H7/(-)-1-(5-Isoquinolinesulfonyl)-2- |
10 mg |
$92.00 |
| |
methylpiperazine, Di-HCl salt |
25 mg |
$160.60 |
| |
C14H17N3O2S.2HCl FW 364.40 [108930-17-2] |
|
|
| |
Inhibitor of PKC, cAMP-dependent kinase, and cGMP-dependent kinase. |
|
|
| |
Kawamoto S, Hidaka H. Biochem Biophys Res Comm. 125:258-64 (1984). |
|
|
| |
|
|
|
| H0002 |
H8/ N-[2-(Methylamino)ethyl]-5- |
5 mg |
$50.20 |
| |
isoquinolinesulfonamide, Di-HCl Salt} |
25 mg |
$144.30 |
| |
C13H15N3O2S.2HCl FW 338.20 [113276-94-1] |
|
|
| |
A potent inhibitor of PKA and cAMP. |
|
|
| |
Jung CS, Lee SJ, Paik SS et al. Neuroscience Lett. 282:53-6 (2000). |
|
|
| |
Rosado E, Schwartz Z, Sylvia VL et al. Biochim Biophys Acta. 1590:1-15 (2002). |
|
|
| |
|
|
|
| H0003 |
H89/ (N-[2-[P-Bromocinnamylamino]-ethyl)- |
1 mg |
$43.90 |
| |
5-isoquinolinesulfonmide) |
5 mg |
$110.40 |
| |
C20H20BrN3O2S FW 446.36 [127243-85-0] |
|
|
| |
Selective potent inhibitor of CAMP-dependent protein kinase (PKA). |
|
|
| |
Murol M, Suzuki T. Cell Signal. 5:289 (1993). |
|
|
| |
|
|
|
| H0100 |
HA Peptide |
1 mg |
$71.70 |
| |
C53H67N9O17 FW 1102.18 |
2 mg |
$121.90 |
| |
|
5 mg |
$215.00 |
| |
|
|
|
| H0142 |
Haloperidol |
5 g |
$60.30 |
| |
C21H23ClFNO2 FW 375.86 [52-86-8] |
10 g |
$106.60 |
| |
A typical antipsychotic, that has been shown to alter GABA transporter |
25 g |
$238.30 |
| |
expression in rats. It has also been shown to induce apoptosis of neurons in the |
|
|
| |
striatum and substantia nigra of rat. |
|
|
| |
Mitchell IJ, Cooper AC, Griffiths MR et al. Neuroscience. 109:89-99 (2002). |
|
|
| |
Zink M, Schmitt A, May B et al. Pharmacopsychiatry. 37:171-4 (2004). |
|
|
| |
|
|
|
| H0169 |
Harringtonin |
5 mg |
$76.50 |
| |
C28H37NO9 FW 531.59 [26833-85-2] |
10 mg |
$131.90 |
| |
Alkaloid isolated from Cephalotaxus. Antitumor agent. |
25 mg |
$261.60 |
| |
Power RG. Phytochemistry. 11:1467-1472 (1972). |
|
|
| |
|
|
|
| |
|
|
|
| H0207 |
HBV core protein (128-140) |
0.5 mg |
$43.00 |
| |
C66H103N17O17 FW 1406.64 |
1 mg |
$73.50 |
| |
|
2.5 mg |
$129.00 |
| |
|
|
|
| H1643 |
Helodermin |
0.5 mg |
$136.20 |
| |
C176H283N45O51 FW 3845.49 |
1 mg |
$231.20 |
| |
A VIP/secretin-like peptide that was originally isolated from Gila monster venom. |
2.5 mg |
$408.60 |
| |
Bjartell A, Persson P, Absood A et al. Regul Pept. 26:27-34 (1989). |
|
|
| |
|
|
|
| H1644 |
Helodormin |
1 mg |
$412.20 |
| |
C176H285N47O49 FW 3843.47 |
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| H1645 |
Helospectin I |
1 mg |
$336.90 |
| |
C183H293N47O59 FW 4095.66 |
2 mg |
$573.40 |
| |
|
5 mg |
$1,010.70 |
| |
|
|
|
| H1646 |
Helospectin II |
1 mg |
$336.90 |
| |
C180H288N46O57 FW 4008.58 |
2 mg |
$573.40 |
| |
|
5 mg |
$1,010.70 |
| |
|
|
|
| |
|
|
|
| H1648 |
Hemorphin-7 |
1 mg |
$71.70 |
| |
C49H64N12O11 FW 997.12 |
2 mg |
$121.90 |
| |
|
5 mg |
$215.00 |
| |
|
|
|
| H1657 |
Heparin-Binding Peptide |
0.5 mg |
$43.00 |
| |
C47H74N16O10 FW 1023.22 |
1 mg |
$73.50 |
| |
|
2.5 mg |
$129.00 |
| |
|
|
|
| H1658 |
Heparin Sodium |
1 g |
$65.40 |
| |
[9041-08-1] |
|
|
| |
Derived from intestinal mucosa. Anticogulant heparin enhances blood coagulation |
|
|
| |
and fibrinolysis during hemodialysis with prostacyclin. |
|
|
| |
Kandrotas RJ. Clin Pharmacokinet 22: 359-74 (1992). |
|
|
| |
Hirsh J, Heparin N. Engl J. Med. 324:1565-74 (1991). |
|
|
| |
|
|
|
| H1661 |
Hepatitis B Virus core protein (128-140) |
1 mg |
$140.60 |
| |
HBV Core protein (128-140) |
|
|
| |
C66H103N17O17 FW 1406.64 |
|
|
| |
|
|
|
| H1660 |
2-n-Heptylfuran |
10 g |
$98.80 |
| |
C11H18O FW 166.27 b.p. 96-970C/30mm [3777-71-7] |
20 g |
$180.80 |
| |
Inhibitor of BP-induced lung and forestomach tumorigenesis in mice. |
|
|
| |
Lam LK et al. Nutr. Cancer. 17:19-26 (1992). |
|
|
| |
|
|
|
| H1662 |
HER2/neu (654-662) GP2 |
1 mg |
$71.70 |
| |
C42H77N9O11 FW 884.12 |
2 mg |
$121.90 |
| |
|
5 mg |
$215.00 |
| |
|
|
|
| H1663 |
HER2/neu (869-877) |
1 mg |
$43.00 |
| |
C49H75N9O20 FW 1110.19 |
2 mg |
$73.50 |
| |
|
5 mg |
$129.00 |
| |
|
|
|
| H1669 |
Herbimycin A |
100 µg |
$225.20 |
| |
C30H42N2O9 FW 574.7 [70563-58-5] |
|
|
| |
Tyrosine kinase inhibitor; cell permeable, inhibits platelet derived |
|
|
| |
growth factor induced phospholipase D activation. |
|
|
| |
Satoh T et al. J. Biolchem. 267:2537 (1992). |
|
|
| |
|
|
|
| H1672 |
Hesperetin |
1 g |
$20.60 |
| |
C16H14O6 FW 302.3 [41001-90-5] |
5 g |
$64.30 |
| |
The aglycone of Hesperidin. |
10 g |
$102.60 |
| |
|
|
|
| |
|
|
|
| H1673 |
Hesperidin |
25 g |
$16.70 |
| |
C28H34O15 FW 610.6 [520-26-3] |
100 g |
$40.50 |
| |
A flavonoid which has been found to be a potent chemopreventive agent |
|
|
| |
in oral, colon, and urinary bladder carcinogenesis in animal models. |
|
|
| |
Tanaka T, Makita H, Ohnishi M et al. Cancer Res. 57:246-252 (1997) |
|
|
| |
Tanaka T, Makita H, Kawabata K et al. Carcinogenesis. 18:957-965 (1997). |
|
|
| |
Yang M, Tanaka T, Hirose Y et al. Int. J. Cancer. 73:719-724 (1997). |
|
|
| |
|
|
|
| H1695 |
S-Hexyglutathione |
100mg |
$50.40 |
| |
C16H29N3O6S FW 391.50 [24425-56-7] |
250mg |
$84.00 |
| |
|
1 g |
$258.94 |
| |
|
|
|
| H1794 |
Hexamethonium bromide hydrate |
10 g |
$27.60 |
| |
C12H30Br2N2.xH2O FW 362.20 [55-97-0] |
25 g |
$48.40 |
| |
A nicotinic acetyl choline receptor antagonist. It induces apoptosis and inhibits |
100 g |
$141.10 |
| |
the stimulatory effect of nicotine on endothelial cell DNA synthesis and proliferation. |
|
|
| |
It is also effective in preventing organophosphate intoxication. |
|
|
| |
Vallablanca AC, J appl Physiol. 84:2089-98 (1998). |
|
|
| |
Maneckjee R, Minna JD. Cell Growth Differ. 5:1033-40 (1994). |
|
|
| |
Sanchez-Fortun S, Sanz F, Barahona MV. Arch Environ Contam Toxicol. 31:391-8 (1996). |
|
|
| |
|
|
|
| H1892 |
Hexamethylene Biscetamide |
25 g |
$34.50 |
| |
C10H20N2O2 FW 200.28 [3073-59-4] |
50 g |
$55.10 |
| |
Prototype of hybrid polar inducers of apoptosis of various transformed cells. |
|
|
| |
Marks PA, Richon VM, Breslow R, Rifkind RA. C R Acad Sci III 322:161-5 (1999). |
|
|
| |
|
|
|
| H1893 |
Hexarelin |
1 mg |
$96.30 |
| |
C47H58N12O6 FW 887.0 [140703-51-1] |
5 mg |
$401.40 |
| |
A growth hormone secretagogue that has been shown to inhibit apoptosis in |
50 mg |
$2,007.00 |
| |
several models. It is suggested that the inhibitory activity could be explained |
|
|
| |
by its cardioprotective effect. |
|
|
| |
Pang JJ, Xu RK, Xu XB et al. Am J Physiol Heart Circ Physiol. 286:H1063-9 (2004). |
|
|
| |
Filigheddu N, Fubini A, Baldanzi G et al. Endocrine. 14:113-9 (2001). |
|
|
| |
|
|
|
| H1894 |
Hexestrol |
1 g |
$41.40 |
| |
C18H22O2 FW 270.37 [84-16-2] |
5 g |
$124.20 |
| |
A carcinogenic synthetic estrogen that inhibits microtubule polymerization and the formation |
|
|
| |
of ribbon structures. It is an inhibitor of lipid peroxidation. |
|
|
| |
Sato et al. J. Biochem. 101:1247-1252 (1987). |
|
|
| |
Wiseman H, Halliwell B. FEBS Lett. 332:159-63 (1993). |
|
|
| |
Liehr JG, Ballatore AM, Dague BB. Chem Biol Interact. 55:157-76 (1985). |
|
|
| |
|
|
|
| H3272 |
His Tag |
5 mg |
$215.00 |
| |
C36H42N18O6 FW 822.85 |
|
|
| |
|
|
|
| H3273 |
Histatin 5 |
0.5 mg |
$136.20 |
| |
C133H195N51O33 FW 3036.36 |
1 mg |
$231.20 |
| |
|
2.5 mg |
$408.60 |
| |
|
|
|
| H3277 |
Histrelin Acetate |
Please inquire |
|
| |
C66H86N18O12 FW 1323.52 [76712-82-8] |
|
|
| |
Histrelin acetate is a potent LHRH agonist. For the treatment of central precocious puberty. |
|
|
| |
|
|
|
| H3274 |
HIV p17 Gag (77-85) |
1 mg |
$89.60 |
| |
C44H72N10O15 FW 981.1 |
2 mg |
$152.30 |
| |
|
5 mg |
$268.80 |
| |
|
|
|
| H3275 |
HIV Integrase Protein Inhibitor(1) |
1 mg |
$35.80 |
| |
C46H55N11O7S FW 906.1 |
2 mg |
$60.90 |
| |
|
5 mg |
$107.50 |
| |
|
|
|
| H3276 |
HIV Protease Substrate |
1 mg |
$107.50 |
| |
C33H59N11O10 FW 769.9 |
|
|
| |
|
|
|
| |
|
|
|
| H3278 |
HIV RT (pol) A2.1 peptide |
1 mg |
$43.00 |
| |
|
2 mg |
$73.50 |
| |
|
5 mg |
$129.00 |
| |
|
|
|
| |
HMG (Human Menopausal Gonadotropins) (See Menotropins) |
|
|
| |
|
|
|
| H5748 |
DL-Homocysteine thiolactone hydrochloride |
50 g |
$47.40 |
| |
C4H7NOS.HCl FW 153.63 m.p. 201-2020C [6038-19-3] |
100 g |
$65.40 |
| |
|
|
|
| |
|
|
|
| H5750 |
Homoharringtonin |
1 mg |
$35.40 |
| |
C29H39NO9 FW 545.62 [26833-87-4] |
5 mg |
$139.00 |
| |
Homoharringtonin is an alkaloid isolated from Cephalotaxus hainanensis. |
10 mg |
$224.30 |
| |
Found to have antitumor activities. |
|
|
| |
Corbett TH, Griswold DP, Roberts BJ et al. Cancer. 40:2660-2680 (1977). |
|
|
| |
Powell RG, Rogovin SP, Smith CR. Ind. Eng. Chem. Prod. Res. Dev. 13:129-132 (1974). |
|
|
| |
|
|
|
| H5654 |
Honokiol |
10 mg |
$72.90 |
| |
C18H18O2 FW 266.33 [35354-74-6] |
25 mg |
$154.90 |
| |
A phenolic compound isolated from Magnolia officinalis. It has many |
100 mg |
$494.90 |
| |
interesting biological activities. Inhibits leukotriene synthesis, protects rat |
|
|
| |
heart mitochondria and liver from peroxidative injury, and has anxiolytic and antiarrhythmic |
|
|
| |
effects. Possesses antimicrobial and antifungal activity. Found to |
|
|
| |
induce apoptosis in human squamous lung cancer CH27 cells. |
|
|
| |
Yang SE, Hsieh MT, Tsai TH, Hsu SL. Biochem Pharm. 63:1641-1651 (2002). |
|
|
| |
Hamasaki Y, Muro E, Miyanji S et al. Int. Arch Allergy Immun. 110:278-281 (1996). |
|
|
| |
Lo YC, Teng CM, Chen CF Et al. Biochem Pharm. 47:549-553 (1994). |
|
|
| |
Kuribara H, Stavinoha WB, Maruyama Y. J Pharm Pharm. 50:819-826 (1998). |
|
|
| |
|
|
|
| H2876 |
H-Trp-Gly-OH |
1 mg |
$125.40 |
| |
C13H13N3O2 FW 261.28 |
|
|
| |
|
|
|
| H8048 |
Human Follicular Gonadotropin Releasing Peptide |
1 mg |
$140.60 |
| |
(Hf-GRP) |
|
|
| |
C68H94N22O27 FW 1651.6 |
|
|
| |
|
|
|
| H2980 |
Humanin, human |
0.5 mg |
$136.20 |
| |
C119H204N34O32S2 FW 2687.28 |
1 mg |
$233.00 |
| |
Inhibits neuronal cell death caused by Swedish mutant (K595N/M596L-APP.). |
2.5 mg |
$408.60 |
| |
Hashimoto Y, Ito Y, Niikura T et al. Biochem Biophys Res Commun. 283:460-468 (2001). |
|
|
| |
|
|
|
| H8162 |
Huperzine A |
1 mg |
$81.50 |
| |
C15H18N2O FW 242.32 [102518-79-6] |
5 mg |
$313.60 |
| |
Natural product from Lycopodium serratum Thunb. It is a potent acetylcholinesterase inhibitor |
|
|
| |
with neuroprotective properties that are of interest in the treatment of Alzheimer's disease. It has |
|
|
| |
been shown to inhibit staurosporine-induced apoptosis. |
|
|
| |
Zhang HY, Tang XC. Neurosci Lett. 340:91-4 (2003). |
|
|
| |
Wang LS, Zhou J, Shao XM et al. Zhonghua Er Ke Za Zhi. 41:42-5 (2003). |
|
|
| |
Zhang HY, Yan H, Tang XC. Neuosci Lett. 360:21-4 (2004). |
|
|
| |
|
|
|
| H9801 |
Hyaluronic Acid Sodium salt |
100 mg |
$34.50 |
| |
From Streptococcus |
500 mg |
$103.50 |
| |
Hyaluronic acid is a major non-protein glycosnaine glycan component of |
1 g |
$172.50 |
| |
extracellular matrix in mammalian cells. |
|
|
| |
Meyer K, Palmer JW. J. Biol. Chem. 107:629 (1934). |
|
|
| |
|
|
|
| H9611 |
Hydrocortisone |
5 g |
$60.40 |
| |
C21H30O5 FW 362.46 [50-23-7] |
10 g |
$103.30 |
| |
An anti-inflammatory steroid, found to increase apoptotic events when used in |
25 g |
$206.60 |
| |
combination with mifepristine in human LNcap prostate cancer cells. Inhibits |
|
|
| |
angiogenesis by abolishing VEGF expression. Known to inhibit superoxide generation. |
|
|
| |
El, Etreby MF, Liang Y, Lewis RW. Prostate. 43:31-42 (2000). |
|
|
| |
Nauck M, Karakiulakis G, Perruchoud AP et al. Eur J Pharmacol. 341:309-15 (1998). |
|
|
| |
Okada Y, Okada M. J Nutr Sci Vitaminol (Tokyo). 46:1-6, (2000). |
|
|
| |
|
|
|
| H9612 |
Hydrocortisone 21-acetate |
1 g |
$27.70 |
| |
C23H32O6 FW 404.50 [50-03-3] |
5 g |
$103.50 |
| |
A corticosteroid with anti-inflammatory properties. It may stimulate superoxide |
10 g |
$172.50 |
| |
dismutase production and may release antioxidants. |
|
|
| |
Gavan N, Maibach H. Skin Pharmacol. 10:309-13 (1997). |
|
|
| |
Michniak BB, Chapman JM, Seyda KL. J Pharm Sci. 82:214-9 (1993). |
|
|
| |
|
|
|
| H9618 |
Hydroquinone |
50 g |
$23.30 |
| |
C6H6O2 FW 110.11 [123-31-9] |
|
|
| |
Topical hydroquinone is used in the treatment of a number of skin conditions. Found to reduce |
|
|
| |
the viable cell number of oral tumor cell. |
|
|
| |
Ozluer SM, Muir J, Australas J. Dermatol. 4:255-6 (2000). |
|
|
| |
Terasaka H, Takayama F, Satoh K, Fujisawa S, Sakagami H. Anticancer Res. 20:3357-62 (2000). |
|
|
| |
|
|
|
| H9620 |
7-Hydroxyaristolochic acid A |
1 mg |
$106.50 |
| |
C17H11NO8 FW 357-27 [475-80-9] |
5 mg |
$409.90 |
| |
See aristolochic acid A. |
10 mg |
$573.80 |
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
20-Hydroxyecdysone (See ecdysterone) |
|
|
| |
|
|
|
| H9615 |
17a-Hydroxyprogesterone |
1 g |
$19.20 |
| |
C21H30O3 FW 330.46 [68-96-2] |
5 g |
$60.40 |
| |
An antiestrogen used to treat advanced endometrial cancer and breast cancer. |
10 g |
$103.30 |
| |
Reifenstein EC, Cancer. 27:485-502 (1971). |
|
|
| |
Pasqualini JR, Paris J, Sitruk-Ware R et al. J Steroid Biochem Mol Biol. 65:225-35 (1998). |
|
|
| |
|
|
|
| H9718 |
2-Hydroxy-flutamide |
10 mg |
$106.50 |
| |
C11H11F3N2O4 FW 292.21 [52806-53-8] |
25 mg |
$205.10 |
| |
Metabolite of flutamide found to inhibit the proliferation of estradiol-induced |
100 mg |
$737.70 |
| |
growth of MCF-7 breast cancer cells. |
|
|
| |
Shet MS, McPhaul M, Fisher CW et al. Drug Metab Dispos. 25:1298-303 (1997). |
|
|
| |
Di Monaco M, Brignardello E, Leonardi L et al. J Cancer Res Clin Oncol. 121:710-4 (1995). |
|
|
| |
|
|
|
| H9613 |
N-(4-Hydroxyphenyl) retinamide |
1 mg |
$66.30 |
| |
Fenretinide, 4-HPR |
5 mg |
$129.80 |
| |
C26H33NO2 FW 391.55 m.p. 173-1750C [65646-68-6] |
10 mg |
$241.50 |
| |
A synthetic analog of vitamin A without the observed liver toxicity. Cancer |
|
|
| |
chemopreventive agent. Induces apoptosis in human cancer cell lines. |
|
|
| |
Moon RC, Thompson HJ, Becci PJ et al. Cancer Res. 39:1339-1346 (1979). |
|
|
| |
Kalemkerian GP, Slusher R, Ramalingam S. J Natl Cancer Inst. 87:1674-80 (1995). |
|
|
| |
|
|
|
| H9711 |
(Z)-4-Hydroxytamoxifen |
5 mg |
$68.90 |
| |
C26H29NO2 FW 387.51 [68047-06-3] |
10 mg |
$114.80 |
| |
An active metabolite of (Z)-tamoxifen which exhibits higher potency as |
25 mg |
$238.80 |
| |
estrogen agonist. It binds to estrogen receptors with 8-fold higher affinity than tamoxifen. |
|
|
| |
Kupfer D et al Cancer Res. 54:3140 (1994). |
|
|
| |
Lubczyk V, Bachmann H, Gust R J. Med. Chem. 45:5358 (2002). |
|
|
| |
|
|
|
| H9712 |
(E)-4-Hydroxytamoxifen |
5 mg |
$89.40 |
| |
C26H29NO2 FW 387.51 [174592-47-3] |
10 mg |
$149.00 |
| |
Less active isomer of (Z)-4-hydroxytamoxifen. |
25 mg |
$310.40 |
| |
RobertsonDW,KatzenellenbogenJA,LongDJ,RorkeEA,Katzenellenbogen BS J. Steroid Boichem. |
|
|
| |
16:1 (1982). |
|
|
| |
|
|
|
| H9716 |
(E, Z)-4-Hydroxytamoxifen |
5 mg |
$28.20 |
| |
C26H29NO2 FW 387.51 |
10 mg |
$46.90 |
| |
Mixture of cis- and trans-isomers of 4-hydroxytamoxifen. |
25 mg |
$97.80 |
| |
|
|
|
| H9714 |
5-Hydroxy-L-tryptophan |
250 mg |
$18.30 |
| |
L-5-HTP |
1 g |
$30.50 |
| |
C11H12N2O3.H2O FW 238.24 [314062-44-7] |
5 g |
$83.60 |
| |
|
25 g |
$318.80 |
| |
|
|
|
| |
3-Hydroxytyrosol (See 3,4-Dihydroxyphenyl Ethanol) |
|
|
| |
|
|
|
| H9715 |
Hydroxyurea |
5 g |
$80.60 |
| |
CH4N2O2 FW 76.06 |
10 g |
$116.50 |
| |
Anticancer agent. |
50 g |
$447.60 |
| |
Argiris A, Haraf DJ, Kies MS, Vokes EE. Oncologist. 8:350-60 (2003). |
|
|
| |
Halsey C, Roberts IA. Haematol.121:200 (2003). |
|
|
| |
|
|
|
| H9717 |
Hydroxyzine Dihydrochloride |
5 g |
$35.20 |
| |
C21H27ClN2O2.2HCl FW 447.83 [2192-20-3] |
10 g |
$56.40 |
| |
A piperazine compound. It is a heterocyclic histamine-1 receptor antagonist that is also |
|
|
| |
known to block mast cells. |
|
|
| |
Gerber JG, Skoglund ML, Nies AS. Agents Actions. 12:259-62 (1982). |
|
|
| |
Dimitriadou V, Pang X, Theoharides TC. Int J Immunopharmacol. 22:673-84 (2000). |
|
|
| |
|
|
|
| |
Hyoscine Butyl Bromide |
|
|
| |
Scopolamine N-Butyl Bromide |
|
|
| |
|
|
|
| H9759 |
Hypaconitine |
10 mg |
$87.80 |
| |
C33H45NO10 FW 615.71 [6900-87-4] |
25 mg |
$163.10 |
| |
A diterpene alkaloid isolated from Aconiti Carmichaeli Praeparata that is a |
100 mg |
$501.80 |
| |
neuromuscular blocker. |
|
|
| |
Shim SH, Kim JS, Kang SS et al. Arch Pharm Res. 26:709-15 (2003). |
|
|
| |
Muroi M, Kimura I, Kimura M. Neuropharmacology. 29:567-72 (1990). |
|
|
| |
|
|
|
| H9861 |
Hypericin |
1 mg |
$132.20 |
| |
C30H16O8 FW 504.44 [548-04-9] |
5 mg |
$448.00 |
| |
Natural product from Hypericum perforatum (St. John's wort). It is an inhibitor of PKC. |
|
|
| |
It has antiviral and anticancer activities and induces photosensitized apoptosis. |
|
|
| |
Couldwell WT, Gopalakrishna R, Hinton DR et al. Neurosurgery. 35:705-9 (1994). |
|
|
| |
Weller M, Trepel M, Grimmel C, et al. Neurol Res. 19:459-70 (1997). |
|
|
| |
Lavie G, Kaplinsky C, Toren A et al. Br J Cancer. 79:423-32 (1999). |
|
|
| |
|
|
|
| H9662 |
Hypocrellin B |
10 mg |
$129.20 |
| |
C30H24O9 FW 528.51 |
25 mg |
$241.10 |
| |
|
100 mg |
$602.60 |
| |
|
|
|
| H9763 |
Hypoxanthine |
5 g |
$18.70 |
| |
C5H4N4O FW 136.11 [68-94-0] |
25 g |
$53.90 |
| |
A marker for energy perturbation in hypoxia/ischemia and uric acid production. |
100 g |
$172.50 |
| |
Marklund N, Ostman B, Nalmo L et al. Acta Neurochir (Wien). 142:1135-41 (2000). |
|
|
| |
|
|
|